• Skip navigation
  • Skip to navigation
  • Skip to the bottom
Simulate organization breadcrumb open Simulate organization breadcrumb close
Friedrich-Alexander-Universität Faculty of Medicine
  • FAUTo the central FAU website
  • English
  • Deutsch
  • Universitätsklinikum Erlangen
  • UnivIS
  • Contact us
Friedrich-Alexander-Universität Faculty of Medicine
Navigation Navigation close
  • Faculty
    • Institutes and Departments
    • Faculty Board of Directors
    • Faculty Committees
    • Dean’s Office
    • Honors and Prizes
    Portal Faculty
  • Study
    • Medicine
    • Medicine Erlangen-Nürnberg/Bayreuth
    • Dentistry
    • Molecular Medicine, B.Sc.
    • Molecular Medicine, M.Sc.
    • Medical Process Management, M.Sc.
    • Logopedics, B.Sc.
    • Advanced ImmunoMedicine, Ph.D.
    • Doctorates
    Portal Study
  • Research
    • Research Profile
    • Institutions and Projects
    • Services for Researchers
    • Young researchers
    Portal Research
  • International
    • Student Mobility
    • Researcher Mobility
    • International Collaborative Research
    Portal International
  1. Home
  2. Research
  3. Institutions and Projects
  4. Collaborative Research
  5. Bavaria

Bavaria

In page navigation: Research
  • Research Profile
    • Core Research Areas
    • Research Report
  • Institutions and Projects
    • Collaborative Research
      • DFG
      • BMBF
      • EU
      • Bavaria
    • Central Institutes and Interdisciplinary Centers
    • Research Infrastructure
  • Services for Researchers
    • Support and Advice
    • Research Funding
    • Transfer of Research Results
  • Young researchers
    • Doctorates
    • Structured Doctoral Programs
    • Habilitation and Adjunct Professorship

Bavaria

Collaborative research funded by the state of Bavaria

Bavarian Research Network Induced Pluripotent Stem Cells (ForIPS)

The Bavarian Research Network ForIPS has the major and long-term goal to establish human cellular disease models and novel intervention strategies for sporadic and chronic disorders of the brain with the current focus on sporadic Parkinson’s disease. The first task of the ForIPS consortium is to establish a biobank for human induced pluripotent stem cells (IPS) of Parkinson’s disease patients and healthy controls at the Universitätsklinikum Erlangen including the implementation important quality controls in terms of genomic and transcriptional stability as well as the development of non-integrating reprogramming strategies. Reprogramming of mature cells of the body into so called “induced pluripotent stem cells” represents one of the most innovative biomedical developments in recent years (Nobel Prize in Medicine, 2012). Using this technology, connective tissue cells of patients are obtained and reprogrammed to the stage of pluripotency. As a result, patient specific stem cells are generated and in the framework of ForIPS further differentiated to neurons. Using this technology, ForIPS is able to generate IPS-derived neurons from affected patients. These cells may serve as a cellular model for the analysis of individual disease mechanisms, in particular with regard to the individually underlying pathogenesis of the patient, thus enabling the development of new treatment strategies.

Contact: Prof. Dr. Jürgen Winkler, Division of Molecular Neurology

Research report ForIPS

FAU
Faculty of Medicine

Krankenhausstraße 12
91054 Erlangen
Germany
  • Imprint
  • Privacy
  • Accessibility
  • Jobs
Up